Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2026-01-17 @ 11:06 AM
Study NCT ID:
NCT03574818
Status:
TERMINATED
Last Update Posted:
2020-03-18
First Post:
2018-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001
Sponsor:
Organization: